{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:08:25Z","timestamp":1768777705082,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Canadian Institutes of Health Research (CA)","award":["MCT - 103817"],"award-info":[{"award-number":["MCT - 103817"]}]},{"DOI":"10.13039\/100012453","name":"Providence Health Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"InnerChange Foundation"},{"name":"St. Paul's Foundation (CA)"},{"name":"Vancouver Coastal Health Research Institute (CA)"},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs, Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13011-017-0110-9","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T06:42:43Z","timestamp":1495176163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Men\u2019s and women\u2019s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder"],"prefix":"10.1186","volume":"12","author":[{"given":"Heather","family":"Palis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslam H.","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"110_CR1","doi-asserted-by":"crossref","unstructured":"Gowing L, Farrell M, Bornemann R, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Library. 2004. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18425898 .","DOI":"10.1002\/14651858.CD004145.pub2"},{"issue":"6","key":"110_CR2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0193841X07307315","volume":"31","author":"YI Hser","year":"2007","unstructured":"Hser YI, et al. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev. 2007;31(6):548\u201363.","journal-title":"Eval Rev"},{"issue":"1","key":"110_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0740-5472(00)00155-0","volume":"20","author":"CL Arfken","year":"2001","unstructured":"Arfken CL, et al. Gender differences in problem severity at assessment and treatment retention. J Subst Abus Treat. 2001;20(1):53\u20137.","journal-title":"J Subst Abus Treat"},{"issue":"9","key":"110_CR4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1081\/JA-120039392","volume":"39","author":"E Puigdollers","year":"2004","unstructured":"Puigdollers E, et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse. 2004;39(9):1353\u201368.","journal-title":"Subst Use Misuse"},{"key":"110_CR5","doi-asserted-by":"crossref","unstructured":"Brady, T.M. and O.S.E. Ashley, Women in substance abuse treatment: Results from the Alcohol and Drug Services Study (ADSS) (DHHS Publication No. SMA 04\u20133968, Analytic Series A-26). Substance Abuse and Mental Health Services Administration, Office of Applied Studies., 2005.","DOI":"10.1037\/e434082005-001"},{"issue":"1","key":"110_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","volume":"86","author":"SF Greenfield","year":"2007","unstructured":"Greenfield SF, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1\u201321.","journal-title":"Drug Alcohol Depend"},{"key":"110_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0149-7189(01)00027-1","volume":"24","author":"YI Hser","year":"2001","unstructured":"Hser YI, et al. Effects of program and patients characteristics on retention of drug treatment patients. Eval Program Plann. 2001;24:331\u201341.","journal-title":"Eval Program Plann"},{"key":"110_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen C, et al. Heroin-assisted treatment for opioid dependence: Randomised controlled trial. Br J Psychiatry. 2007;191:55\u201362.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"110_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drugalcdep.2010.03.016","volume":"11","author":"E Oviedo-Joekes","year":"2010","unstructured":"Oviedo-Joekes E, et al. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. Drug Alcohol Depend. 2010;11(1):50\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"110_CR10","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.eurpsy.2007.01.605","volume":"22","author":"DA Charney","year":"2007","unstructured":"Charney DA, Gill KJ. Impulsivity, Personality Disorders and the Engagement in Addiction Treatment. European Psychiatry. 2007;22:S184.","journal-title":"European Psychiatry"},{"issue":"2","key":"110_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10550490601184225","volume":"16","author":"DA Charney","year":"2007","unstructured":"Charney DA, Palacios-Boix J, Gill KJ. Sexual abuse and the outcome of addiction treatment. Am J Addict. 2007;16(2):93\u2013100.","journal-title":"Am J Addict"},{"issue":"2","key":"110_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","volume":"21","author":"DC Des Jarlais","year":"2007","unstructured":"Des Jarlais DC, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007;21(2):231\u20135.","journal-title":"AIDS"},{"key":"110_CR13","first-page":"3","volume":"82","author":"L Doyal","year":"2004","unstructured":"Doyal L. Gender and the 10\/90 gap in health research. Bull World Health Organ. 2004;82:3.","journal-title":"Bull World Health Organ"},{"key":"110_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-9276-8-14","volume":"8","author":"JL Johnson","year":"2009","unstructured":"Johnson JL, Greaves L, Repta R. Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research. Int J Equity Health. 2009;8:14.","journal-title":"Int J Equity Health"},{"issue":"1","key":"110_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0193841X07307318","volume":"32","author":"CE Grella","year":"2008","unstructured":"Grella CE, et al. Gender similarities and differences in the treatment, relapse, and recovery cycle. Eval Rev. 2008;32(1):113\u201337.","journal-title":"Eval Rev"},{"issue":"4","key":"110_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1521-0391.2010.00049.x","volume":"19","author":"FJ Eiroa-Orosa","year":"2010","unstructured":"Eiroa-Orosa FJ, et al. Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial. Am J Addict. 2010;19(4):312\u20138.","journal-title":"Am J Addict"},{"key":"110_CR17","first-page":"50","volume-title":"Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women, in Drug Alcohol Depend","author":"E Oviedo-Joekes","year":"2010","unstructured":"Oviedo-Joekes E, et al. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women, in Drug Alcohol Depend. Ireland: 2010 Elsevier Ireland Ltd; 2010. p. 50\u20137."},{"key":"110_CR18","doi-asserted-by":"crossref","unstructured":"Bourgois P, Hart LK. Commentary on Genberg et al. (2011): the structural vulnerability imposed by hypersegregated US inner-city neighborhoods--a theoretical and practical challenge for substance abuse research. Addiction, 2011. 106(11):1975\u20137.","DOI":"10.1111\/j.1360-0443.2011.03615.x"},{"issue":"4","key":"110_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/01459740.2011.576725","volume":"30","author":"J Quesada","year":"2011","unstructured":"Quesada J, Hart LK, Bourgois P. Structural vulnerability and health: Latino migrant laborers in the United States. Med Anthropol. 2011;30(4):339\u201362.","journal-title":"Med Anthropol"},{"issue":"3","key":"110_CR20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.addbeh.2011.11.028","volume":"37","author":"CE Grella","year":"2012","unstructured":"Grella CE, Lovinger K. Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addict Behav. 2012;37(3):306\u201312.","journal-title":"Addict Behav"},{"issue":"3","key":"110_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACM.0000000000001294","volume":"92","author":"P Bourgois","year":"2016","unstructured":"Bourgois P, et al. Structural Vulnerability: Operationalizing the Concept to Address Health Disparities in Clinical Care. Acad Med. 2016;92(3):299\u2013307.","journal-title":"Acad Med"},{"issue":"4","key":"110_CR22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/nin.12096","volume":"22","author":"LG Cox","year":"2015","unstructured":"Cox LG, Simpson A. Cultural safety, diversity and the servicer user and carer movement in mental health research. Nurs Inq. 2015;22(4):306\u201316.","journal-title":"Nurs Inq"},{"issue":"12","key":"110_CR23","first-page":"990","volume":"37","author":"HT Nguyen","year":"2008","unstructured":"Nguyen HT. Patient centred care - cultural safety in indigenous health. Aust Fam Physician. 2008;37(12):990\u20134.","journal-title":"Aust Fam Physician"},{"issue":"2","key":"110_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/ANS.0000000000000070","volume":"38","author":"BB Pauly","year":"2015","unstructured":"Pauly BB, McCall J, Browne AJ, Parker J, Mollison A. Toward cultural safety: nurse and patient perceptions of illicit substance use in a hospitalized setting. Adv Nurs Sci. 2015;38(2):121\u201335.","journal-title":"Adv Nurs Sci"},{"issue":"3","key":"110_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7748\/nr2002.04.9.3.42.c6188","volume":"9","author":"V Smye","year":"2002","unstructured":"Smye V, Browne AJ. \u2018Cultural safety\u2019 and the analysis of health policy affecting aboriginal people. Nurse Res. 2002;9(3):42\u201356.","journal-title":"Nurse Res"},{"issue":"6","key":"110_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/09638237.2012.734653","volume":"22","author":"J Trujols","year":"2013","unstructured":"Trujols J, et al. Patient-reported outcome measures: are they patient-generated, patient-centred or patient-valued? J Ment Health. 2013;22(6):555\u201362.","journal-title":"J Ment Health"},{"issue":"4","key":"110_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11469-007-9116-2","volume":"7","author":"J Pulford","year":"2009","unstructured":"Pulford J, Adams P, Sheridan J. Client\/clinician discrepancies in perceived problem improvement and the potential influence on dropout response. Int J Ment Heal Addict. 2009;7(4):497\u2013505.","journal-title":"Int J Ment Heal Addict"},{"issue":"1","key":"110_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11205-008-9315-7","volume":"90","author":"JV De Maeyer","year":"2009","unstructured":"De Maeyer JV, Broekaert W. E., Exploratory study on drug users\u2019 perspectives on quality of life: More than health-related quality of life? Soc Indic Res. 2009;90(1):107\u201326.","journal-title":"Soc Indic Res"},{"issue":"5","key":"110_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2016.0109","volume":"73","author":"E Oviedo-Joekes","year":"2016","unstructured":"Oviedo-Joekes E, et al. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial. JAMA Psychiatry. 2016;73(5):1\u20139.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"110_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1747-597X-10-3","volume":"10","author":"E Oviedo-Joekes","year":"2015","unstructured":"Oviedo-Joekes E, et al. The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency. Subst Abuse Treat, Prev Policy. 2015;10(1):3.","journal-title":"Subst Abuse Treat, Prev Policy"},{"issue":"1","key":"110_CR31","first-page":"1015","volume":"3","author":"E Oviedo-Joekes","year":"2015","unstructured":"Oviedo-Joekes E, et al. History of Treatment Access and Drug Use among Participants in a Trial Testing Injectable Opioids Under Supervision for Long-Term Heroin Injectors. J Addiction Med Ther. 2015;3(1):1015.","journal-title":"J Addiction Med Ther"},{"issue":"12","key":"110_CR32","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93(12):1857\u201367.","journal-title":"Addiction"},{"key":"110_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, et al. The fifth edition of the Addiction Severity Index. J Subst Abus Treat. 1992;9:199\u2013213.","journal-title":"J Subst Abus Treat"},{"issue":"4","key":"110_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/16066359.2016.1263729","volume":"25","author":"E Oviedo-Joekes","year":"2017","unstructured":"Oviedo-Joekes E, et al. Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder. Addict Res Theory. 2017;25(4):263\u201372.","journal-title":"Addict Res Theory"},{"key":"110_CR35","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1353-0","volume-title":"Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Model","author":"E Vittinghoff","year":"2012","unstructured":"Vittinghoff E. In: Gail M, editor. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Model. New York: Springer; 2012."},{"issue":"4","key":"110_CR36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2307\/2682785","volume":"37","author":"N Laird","year":"1983","unstructured":"Laird N. Further Comparative Analyses of Pretest-Posttest Research Designs. Am Stat. 1983;37(4):329\u201330.","journal-title":"Am Stat"},{"key":"110_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/CLEP.S72247","volume":"7","author":"K Biering","year":"2015","unstructured":"Biering K, Hjollund NH, Frydenberg M. Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clin Epidemiol. 2015;7:91\u2013106.","journal-title":"Clin Epidemiol"},{"key":"110_CR38","unstructured":"S.A.S. Institute. SAS 9.4 for Windows. Cary: SAS Institue Inc.; 2012."},{"key":"110_CR39","volume-title":"Analyzing and interpreting ethnographic data","author":"MD LeCompte","year":"1999","unstructured":"LeCompte MD, Schensul JJ. Analyzing and interpreting ethnographic data. Lanham: Rowman Altamira; 1999."},{"key":"110_CR40","unstructured":"Castleberry A. NVivo 10 [software program]. Version 10. QSR International; 2014."},{"key":"110_CR41","doi-asserted-by":"crossref","unstructured":"Marchand K, Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Schechter MT. Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment. Harm reduction J. 2012;9(8). https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-9-8 .","DOI":"10.1186\/1477-7517-9-8"},{"issue":"14","key":"110_CR42","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1081\/JA-100108441","volume":"36","author":"A Hegamin","year":"2001","unstructured":"Hegamin A, Anglin G, Farabee D. Gender differences in the perception of drug user treatment: assessing drug user treatment for youthful offenders. Subst Use Misuse. 2001;36(14):2159\u201370.","journal-title":"Subst Use Misuse"},{"key":"110_CR43","first-page":"14","volume":"500","author":"K Marchand","year":"2015","unstructured":"Marchand K, et al. The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users. ADM. 2015;500:14\u201300189.","journal-title":"ADM"},{"issue":"8","key":"110_CR44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777\u201386.","journal-title":"N Engl J Med"},{"issue":"9729","key":"110_CR45","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","volume":"375","author":"J Strang","year":"2010","unstructured":"Strang J, et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet. 2010;375(9729):1885\u201395.","journal-title":"Lancet"},{"issue":"2","key":"110_CR46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bcp.12051","volume":"77","author":"J Bell","year":"2014","unstructured":"Bell J. Pharmacological maintenance treatments of opiate addiction. Br J Clin Pharmacol. 2014;77(2):253\u201363.","journal-title":"Br J Clin Pharmacol"},{"issue":"1\u20132","key":"110_CR47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2010.03.019","volume":"111","author":"B Nosyk","year":"2010","unstructured":"Nosyk B, et al. The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug Alcohol Depend. 2010;111(1\u20132):161\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"110_CR48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1465-3362.2008.00015.x","volume":"28","author":"N Romo","year":"2009","unstructured":"Romo N, Poo M, Ballesta R. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain. Drug Alcohol Rev. 2009;28(2):186\u201395.","journal-title":"Drug Alcohol Rev"},{"key":"110_CR49","unstructured":"Oviedo-Joekes, E., et al., \u201cThe problem is that, besides needing the drug, we have lost everything\u201d. The Andalusian heroin trial from the participants\u2019 side. 17th International Conference on the Reduction of Drug Related Harm, April 30 to May 4th. Vancouver, Canada, 2006."},{"issue":"6","key":"110_CR50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dar.12062","volume":"32","author":"T Groshkova","year":"2013","unstructured":"Groshkova T, et al. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug Alcohol Rev. 2013;32(6):566\u201373.","journal-title":"Drug Alcohol Rev"},{"key":"110_CR51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1940-0640-9-21","volume":"9","author":"E Oviedo-Joekes","year":"2014","unstructured":"Oviedo-Joekes E, et al. A chance to stop and breathe: participants\u2019 experiences in the North American Opiate Medication Initiative clinical trial. Addict Sci Clin Pract. 2014;9:21.","journal-title":"Addict Sci Clin Pract"},{"key":"110_CR52","doi-asserted-by":"crossref","unstructured":"Bowen S. Marginalized evidence: Effective knowledge translation strategies for low awareness issues. In Healthcare Management Forum. Los Angeles: SAGE Publications; 2006. 19(2). pp. 38-44.","DOI":"10.1016\/S0840-4704(10)60153-6"},{"issue":"4","key":"110_CR53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1258\/135581905774414213","volume":"10","author":"S Bowen","year":"2005","unstructured":"Bowen S, Martens P. Demystifying knowledge translation: learning from the community. J Health Serv Res Policy. 2005;10(4):203\u201311.","journal-title":"J Health Serv Res Policy"},{"issue":"3","key":"110_CR54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/14737167.7.3.281","volume":"7","author":"S Loukanova","year":"2007","unstructured":"Loukanova S, Molnar R, Bridges JF. Promoting patient empowerment in the healthcare system: highlighting the need for patient-centered drug policy. Expert Rev Pharmacoecon Outcomes Res. 2007;7(3):281\u20139.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-017-0110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:29:13Z","timestamp":1719210553000},"score":1,"resource":{"primary":{"URL":"http:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-017-0110-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1186\/s13011-017-0110-9","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]},"article-number":"25"}}